{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:18:28Z","timestamp":1785935908929,"version":"3.56.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["SPM-07\/0512 (0223)\/2015-EMR-l"],"award-info":[{"award-number":["SPM-07\/0512 (0223)\/2015-EMR-l"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008605","name":"Indian National Science Academy","doi-asserted-by":"publisher","award":["SP\/YSP\/136\/2016-1063"],"award-info":[{"award-number":["SP\/YSP\/136\/2016-1063"]}],"id":[{"id":"10.13039\/100008605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myocardial hypertrophy, an inflammatory condition of cardiac muscles is a maladaptive response of the heart to biomechanical stress, hemodynamic or neurohormonal stimuli. Previous studies indicated that knockout of Arginyltransferase (ATE1) gene in mice and embryos leads to contractile dysfunction, defective cardiovascular development, and impaired angiogenesis. Here we found that in adult rat model, downregulation of ATE1 mitigates cardiac hypertrophic, cardiac fibrosis as well as apoptosis responses in the presence of cardiac stress i.e. renal artery ligation. On contrary, in wild type cells responding to renal artery ligation, there is an increase of cellular ATE1 protein level. Further, we have shown the cardioprotective role of ATE1 silencing is mediated by the interruption of TAK1 activity-dependent JNK1\/2 signaling pathway. We propose that ATE1 knockdown in presence of cardiac stress performs a cardioprotective action and the inhibition of its activity may provide a novel approach for the treatment of cardiac hypertrophy.<\/jats:p>","DOI":"10.1038\/s41598-019-57379-7","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T11:03:05Z","timestamp":1579258985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1\/2 pathway"],"prefix":"10.1038","volume":"10","author":[{"given":"Kanika","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-6280","authenticated-orcid":false,"given":"Santanu","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagartirtha","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameena","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"57379_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese, G. & Lund, L. H. Global public health burden of heart failure. Card. Fail. Rev. 3, 7\u201311 (2017).","journal-title":"Card. Fail. Rev."},{"key":"57379_CR2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","volume":"63","author":"AP Ambrosy","year":"2014","unstructured":"Ambrosy, A. P. et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J. Am. Coll. Cardiol. 63, 1123\u20131133 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"57379_CR3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger, V. L. Epidemiology of heart failure. Circ. Res. 113, 646\u2013659 (2013).","journal-title":"Circ. Res."},{"key":"57379_CR4","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"YK Tham","year":"2015","unstructured":"Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L. & McMullen, J. R. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch. Toxicol. 89, 1401\u20131438 (2015).","journal-title":"Arch. Toxicol."},{"key":"57379_CR5","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1152\/japplphysiol.00374.2015","volume":"119","author":"FR Heinzel","year":"2015","unstructured":"Heinzel, F. R., Hohendanner, F., Jin, G., Sedej, S. & Edelmann, F. Myocardial hypertrophy and its role in heart failure with preserved ejection fraction. J. Appl. Physiol. 119, 1233\u20131242 (2015).","journal-title":"J. Appl. Physiol."},{"key":"57379_CR6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11936-007-0024-3","volume":"9","author":"JE Rame","year":"2007","unstructured":"Rame, J. E. & Dries, D. L. Heart failure and cardiac hypertrophy. Curr. Treat. Options Cardiovasc. Med. 9, 289\u2013301 (2007).","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"57379_CR7","doi-asserted-by":"crossref","unstructured":"Stansfield, W. E. et al. The Pathophysiology of Cardiac Hypertrophy and Heart Failure. In Cellular and Molecular Pathobiology of Cardiovascular Disease, 51\u201378 (2014).","DOI":"10.1016\/B978-0-12-405206-2.00004-1"},{"key":"57379_CR8","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1172\/JCI28884","volume":"116","author":"JC Tardiff","year":"2006","unstructured":"Tardiff, J. C. Cardiac hypertrophy: Stressing out the heart. J. Clin. Invest. 116, 1467\u20131470 (2006).","journal-title":"J. Clin. Invest."},{"key":"57379_CR9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol 15, 387\u2013407 (2018).","journal-title":"Nat. Rev. Cardiol"},{"key":"57379_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu, I. & Minamino, T. Physiological and pathological cardiac hypertrophy. Journal of Molecular and Cellular Cardiology 97, 245\u2013262 (2016).","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"57379_CR11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cvr\/cvq308","volume":"89","author":"EE Creemers","year":"2011","unstructured":"Creemers, E. E. & Pinto, Y. M. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc. Res. 89, 265\u2013272 (2011).","journal-title":"Cardiovasc. Res."},{"key":"57379_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-5-15","volume":"5","author":"D Fan","year":"2012","unstructured":"Fan, D., Takawale, A., Lee, J. & Kassiri, Z. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogen. Tissue Repair 5, 15 (2012).","journal-title":"Fibrogen. Tissue Repair"},{"key":"57379_CR13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong, P., Christia, P. & Frangogiannis, N. G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 71, 549\u2013574 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"57379_CR14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","volume":"363","author":"CY Ho","year":"2010","unstructured":"Ho, C. Y. et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N. Engl. J. Med. 363, 552\u2013563 (2010).","journal-title":"N. Engl. J. Med."},{"key":"57379_CR15","first-page":"838","volume":"38","author":"MD Birnbaum","year":"2019","unstructured":"Birnbaum, M. D. et al. Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis. HHS Public Access. 38, 838\u2013851 (2019).","journal-title":"HHS Public Access."},{"key":"57379_CR16","doi-asserted-by":"publisher","unstructured":"Wang, J. et al. Protein arginylation targets alpha synuclein, facilitates normal brain health, and prevents neurodegeneration. Sci. Rep. 1\u201314, https:\/\/doi.org\/10.1038\/s41598-017-11713-z (2017).","DOI":"10.1038\/s41598-017-11713-z"},{"key":"57379_CR17","first-page":"41","volume":"430","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. Arginyltransferase ATE1 is targeted to the neuronal growth cones and regulates neurite outgrowth during brain development. HHS Public Access. 430, 41\u201351 (2017).","journal-title":"HHS Public Access."},{"key":"57379_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.1069531","volume":"297","author":"YT Kwon","year":"2002","unstructured":"Kwon, Y. T. et al. An essential role of N-terminal arginylation in cardiovascular development. Science 297, 96\u201399 (2002).","journal-title":"Science"},{"key":"57379_CR19","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1242\/dev.022723","volume":"135","author":"R Rai","year":"2008","unstructured":"Rai, R. et al. Arginyltransferase regulates alpha cardiac actin function, myofibril formation and contractility during heart development. Development 135, 3881\u20133889 (2008).","journal-title":"Development"},{"key":"57379_CR20","doi-asserted-by":"crossref","first-page":"24043","DOI":"10.1074\/jbc.M112.364117","volume":"287","author":"MJ Lee","year":"2012","unstructured":"Lee, M. J. et al. Characterization of arginylation branch of N-end rule pathway in G-protein-mediated proliferation and signaling of cardiomyocytes. J. Biol. Chem. 287, 24043\u201324052 (2012).","journal-title":"J. Biol. Chem."},{"key":"57379_CR21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.yjmcc.2012.05.007","volume":"53","author":"S Kurosaka","year":"2012","unstructured":"Kurosaka, S. et al. Arginylation regulates myofibrils to maintain heart function and prevent dilated cardiomyopathy. J. Mol. Cell. Cardiol. 53, 333\u2013341 (2012).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"57379_CR22","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1016\/j.ijcard.2013.05.069","volume":"168","author":"PAB Ribeiro","year":"2013","unstructured":"Ribeiro, P. A. B. et al. Contractility of myofibrils from the heart and diaphragm muscles measured with atomic force cantilevers: Effects of heart-specific deletion of arginyl-tRNA-protein transferase. Int. J. Cardiol. 168, 3564\u20133571 (2013).","journal-title":"Int. J. Cardiol."},{"key":"57379_CR23","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","volume":"583","author":"T Maier","year":"2009","unstructured":"Maier, T., G\u00fcell, M. & Serrano, L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 583, 3966\u20133973 (2009).","journal-title":"FEBS Lett."},{"key":"57379_CR24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ncb984","volume":"5","author":"M Ditzel","year":"2003","unstructured":"Ditzel, M. et al. Degradation of DIAP1 by the N-end rule pathway is essential for regulating apoptosis. Nat. Cell Biol. 5, 467\u2013473 (2003).","journal-title":"Nat. Cell Biol."},{"key":"57379_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.353","volume":"8","author":"K Deka","year":"2017","unstructured":"Deka, K. & Saha, S. Arginylation: a new regulator of mRNA stability and heat stress response. Cell Death Dis. 8, e2604 (2017).","journal-title":"Cell Death Dis."},{"key":"57379_CR26","first-page":"e00611","volume":"37","author":"Ritwik Datta","year":"2017","unstructured":"Datta, Ritwik et al. Myocyte-derived Hsp90 modulates collagen upregulation via biphasic activation of STAT-3 in fibroblasts during cardiac hypertrophy. Mole. Cell. Biol. 37, e00611\u201316 (2017).","journal-title":"Mole. Cell. Biol."},{"key":"57379_CR27","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/jcp.22599","volume":"226","author":"A Chatterjee","year":"2006","unstructured":"Chatterjee, A. et al. Analysis of p53 and NF\u2010\u03baB signaling in modulating the cardiomyocyte fate during hypertrophy. J. cell Physiol. 226, 2543\u20132554 (2006).","journal-title":"J. cell Physiol."},{"key":"57379_CR28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.RES.35.5.775","volume":"35","author":"S Sen","year":"1974","unstructured":"Sen, S. et al. Cardiac hypertrophy in spontaneously hypertensive rats. Circ. Res. 35, 775\u2013781 (1974).","journal-title":"Circ. Res."},{"key":"57379_CR29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2015.01.008","volume":"200","author":"S Rana","year":"2000","unstructured":"Rana, S. et al. A spatio-temporal cardiomyocyte targeted vector system for efficient delivery of therapeutic payloads to regress cardiac hypertrophy abating bystander effect. J. Control. Release 200, 167\u2013178 (2000).","journal-title":"J. Control. Release"},{"key":"57379_CR30","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1101\/gad.1360605","volume":"19","author":"JH Shim","year":"2005","unstructured":"Shim, J. H. et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19, 2668\u20132681 (2005).","journal-title":"Genes Dev."},{"key":"57379_CR31","doi-asserted-by":"crossref","unstructured":"Johnson, G. L. & Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912 (2002).","DOI":"10.1126\/science.1072682"},{"key":"57379_CR32","first-page":"153","volume":"22","author":"G Pearson","year":"2001","unstructured":"Pearson, G. et al. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocrinol Rev. 22, 153\u2013183 (2001).","journal-title":"Endocrinol Rev."},{"key":"57379_CR33","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1242\/jcs.02470","volume":"118","author":"M Qi","year":"2005","unstructured":"Qi, M. & Elion, Ea MAP kinase pathways. J. Cell Sci. 118, 3569\u20133572 (2005).","journal-title":"J. Cell Sci."},{"key":"57379_CR34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/CS20070430","volume":"115","author":"AJ Muslin","year":"2008","unstructured":"Muslin, A. J. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin. Sci. 115, 203\u2013218 (2008).","journal-title":"Clin. Sci."},{"key":"57379_CR35","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.106.679589","volume":"116","author":"Y Wang","year":"2007","unstructured":"Wang, Y. Mitogen-activated protein kinases in heart development and diseases. Circulation 116, 1413\u20131423 (2007).","journal-title":"Circulation"},{"key":"57379_CR36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.RES.83.4.345","volume":"83","author":"PH Sugden","year":"1998","unstructured":"Sugden, P. H. & Clerk, A. \u2018Stress-responsive\u2019 mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ. Res. 83, 345\u2013352 (1998).","journal-title":"Circ. Res."},{"key":"57379_CR37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.physiol.63.1.391","volume":"63","author":"JD Molkentin","year":"2001","unstructured":"Molkentin, J. D. & Dorn, G. W. II Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy. Annu. Rev. Physiol. 63, 391\u2013426 (2001).","journal-title":"Annu. Rev. Physiol."},{"key":"57379_CR38","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1042\/BCJ20160502","volume":"473","author":"MJ Pattison","year":"2016","unstructured":"Pattison, M. J. et al. TLR and TNF-R1 activation of the MKK3\/MKK6-p38 axis in macrophages is mediated by TPL-2 kinase. Biochem. J. 473, 2845\u20132861 (2016).","journal-title":"Biochem. J."},{"key":"57379_CR39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.smim.2014.02.009","volume":"26","author":"G Sabio","year":"2014","unstructured":"Sabio, G. & Davis, R. J. TNF and MAP kinase signalling pathways. Semin. Immunol. 26, 237\u2013245 (2014).","journal-title":"Semin. Immunol."},{"key":"57379_CR40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","volume":"29","author":"A Biernacka","year":"2011","unstructured":"Biernacka, A., Dobaczewski, M. & Frangogiannis, N. G. TGF-\u03b2 signaling in fibrosis. Growth Factors 29, 196\u2013202 (2011).","journal-title":"Growth Factors"},{"key":"57379_CR41","first-page":"9","volume":"38","author":"SH Park","year":"2005","unstructured":"Park, S. H. Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads. J. Biochem Mol. Bio. 38, 9\u201316 (2005).","journal-title":"J. Biochem Mol. Bio."},{"key":"57379_CR42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/cr.2008.308","volume":"19","author":"P L\u00f6nn","year":"2009","unstructured":"L\u00f6nn, P., Mor\u00e9n, A., Raja, E., Dahl, M. & Moustakas, A. Regulating the stability of TGF\u03b2 receptors and Smads. Cell Res. 19, 21\u201335 (2009).","journal-title":"Cell Res."},{"key":"57379_CR43","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1016\/S0021-9258(19)39136-7","volume":"265","author":"E Balzi","year":"1990","unstructured":"Balzi, E., Choder, M., Chen, W. N., Varshavsky, A. & Goffeau, A. Cloning and functional analysis of the arginyl-tRNA-protein transferase gene ATE1 of Saccharomyces cerevisiae. J. Biol. Chem. 265, 7464\u20137471 (1990).","journal-title":"J. Biol. Chem."},{"key":"57379_CR44","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1073\/pnas.0511224103","volume":"103","author":"E Graciet","year":"2006","unstructured":"Graciet, E. et al. Aminoacyl-transferases and the N-end rule pathway of prokaryotic\/eukaryotic specificity in a human pathogen. Proc. Natl. Acad. Sci. 103, 3078\u20133083 (2006).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"57379_CR45","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1128\/MCB.19.1.182","volume":"19","author":"YT Kwon","year":"1999","unstructured":"Kwon, Y. T., Kashina, A. S. & Varshavsky, A. Alternative splicing results in differential expression, activity, and localization of the two forms of arginyl-tRNA-protein transferase, a component of the N-end rule pathway. Mol. Cell. Biol. 19, 182\u2013193 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"57379_CR46","first-page":"2722","volume":"39","author":"CD Waring","year":"2012","unstructured":"Waring, C. D. et al. The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation. Eur. Heart J. 39, 2722\u20132731 (2012).","journal-title":"Eur. Heart J."},{"key":"57379_CR47","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.130","volume":"2","author":"M Chiong","year":"2011","unstructured":"Chiong, M. et al. Cardiomyocyte death: Mechanisms and translational implications. Cell Death Dis. 2, e244 (2011).","journal-title":"Cell Death Dis."},{"key":"57379_CR48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10741-016-9536-9","volume":"21","author":"A Piek","year":"2016","unstructured":"Piek, A., de Boer, R. A. & Sillj\u00e9, H. H. W. The fibrosis-cell death axis in heart failure. Heart Fail. Rev. 21, 199\u2013211 (2016).","journal-title":"Heart Fail. Rev."},{"key":"57379_CR49","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","volume":"583","author":"T Maier","year":"2009","unstructured":"Maier, T., G\u00fcell, M. & Serrano, L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 583, 3966\u20133973 (2009).","journal-title":"FEBS Lett."},{"key":"57379_CR50","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/CIRCULATIONAHA.114.011195","volume":"130","author":"L Li","year":"2014","unstructured":"Li, L. et al. Transforming growth factor \u03b2activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling. Circulation 130, 2162\u20132172 (2014).","journal-title":"Circulation"},{"key":"57379_CR51","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/75037","volume":"6","author":"D Zhang","year":"2000","unstructured":"Zhang, D. et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat. Med. 6, 556\u2013563 (2000).","journal-title":"Nat. Med."},{"key":"57379_CR52","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1042\/BCJ20170288","volume":"474","author":"J Zhang","year":"2017","unstructured":"Zhang, J., Macartney, T., Peggie, M. & Cohen, P. Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3. Biochem. J. 474, 2235\u20132248 (2017).","journal-title":"Biochem. J."},{"key":"57379_CR53","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/ni1255","volume":"6","author":"S Sato","year":"2005","unstructured":"Sato, S. et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087\u20131095 (2005).","journal-title":"Nat. Immunol."},{"key":"57379_CR54","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/HYPERTENSIONAHA.108.120816","volume":"53","author":"J Cai","year":"2009","unstructured":"Cai, J. et al. Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling. Hypertension 53, 539\u2013548 (2009).","journal-title":"Hypertension"},{"key":"57379_CR55","first-page":"69","volume":"117","author":"A Mauviel","year":"2005","unstructured":"Mauviel, A. Transforming growth factor-beta: a key mediator of fibrosis. Methods Mol.Med. 117, 69\u201380 (2005).","journal-title":"Methods Mol.Med."},{"key":"57379_CR56","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1172\/JCI17664","volume":"111","author":"D Wencker","year":"2003","unstructured":"Wencker, D. et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 111, 1497\u20131504 (2003).","journal-title":"J. Clin. Invest."},{"key":"57379_CR57","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/18465","volume":"398","author":"J Ninomiya-Tsuji","year":"1999","unstructured":"Ninomiya-Tsuji, J. et al. The kinase TAK1 can activate the NIK-I\u03baB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398, 252\u2013256 (1999).","journal-title":"Nature"},{"key":"57379_CR58","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35085597","volume":"412","author":"C Wang","year":"2001","unstructured":"Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346\u2013351 (2001).","journal-title":"Nature"},{"key":"57379_CR59","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1074\/jbc.272.13.8141","volume":"272","author":"K Shirakabe","year":"1997","unstructured":"Shirakabe, K. et al. TAK1 mediates the ceramide signaling to stress-activated protein kinase\/c-Jun N-terminal kinase. J. Biol. Chem. 272, 8141\u20138144 (1997).","journal-title":"J. Biol. Chem."},{"key":"57379_CR60","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/emboj.2009.162","volume":"28","author":"JH Shim","year":"2009","unstructured":"Shim, J. H. et al. TAK1 is an essential regulator of BMP signalling in cartilage. EMBO J. 28, 2028\u20132041 (2009).","journal-title":"EMBO J."},{"key":"57379_CR61","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JSC Arthur","year":"2013","unstructured":"Arthur, J. S. C. & Ley, S. C. Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 13, 679\u2013692 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"57379_CR62","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/BJ20140444","volume":"461","author":"J Zhang","year":"2014","unstructured":"Zhang, J., Clark, K., Lawrence, T., Peggie, M. W. & Cohen, P. An unexpected twist to the activation of IKK\u03b2: TAK1 primes IKK\u03b2 for activation by autophosphorylation. Biochem. J. 461, 531\u2013537 (2014).","journal-title":"Biochem. J."}],"updated-by":[{"DOI":"10.1038\/s41598-020-67556-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57379-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57379-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57379-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:56:32Z","timestamp":1670306192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57379-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["57379"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-57379-7","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-020-67556-8","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"598"}}